Kaname Nosaki

Safety and efficacy of pembrolizumab monotherapy in elderly patients with PD-L1–positive advanced non–small-cell lung cancer: Pooled analysis from the KEYNOTE-010, KEYNOTE-024, and KEYNOTE-042 studies

Kaname Nosaki, Hideo Saka, Yukio Hosomi et al. · Lung Cancer · 2019 · 274 citations

Elderly Patients, Medicine, Pembrolizumab Monotherapy +9

The Japanese Lung Cancer Society Guideline for non-small cell lung cancer, stage IV

Hiroaki Akamatsu, Kiichiro Ninomiya, Hirotsugu Kenmotsu et al. · International Journal of Clinical Oncology · 2019 · 145 citations · Full text

Re-biopsy status among non-small cell lung cancer patients in Japan: A retrospective study

Kaname Nosaki, Miyako Satouchi, Takayasu Kurata et al. · Lung Cancer · 2016 · 135 citations · Full text

Phase I, dose-escalation study of AZD7762 alone and in combination with gemcitabine in Japanese patients with advanced solid tumours

Takashi Seto, Taito Esaki, Fumihiko Hirai et al. · Cancer Chemotherapy and Pharmacology · 2013 · 101 citations

Dose-escalation Study, Radiation Medicine, Medicine +10

Monitoring of somatic mutations in circulating cell-free DNA by digital PCR and next-generation sequencing during afatinib treatment in patients with lung adenocarcinoma positive for EGFR activating mutations

Eiji Iwama, Kazuko Sakai, Koichi Azuma et al. · Annals of Oncology · 2016 · 91 citations

Digital Pcr, Oncology, Sequencing +10